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ABSTRACT
Immuno-PCR (IPCR) is a powerful detection techno-
logy in immunological study and clinical diagnosis
due to its ultrasensitivity. Here we introduce a new
strategy termed phage display mediated immuno-
PCR (PD-IPCR). Instead of utilization of monoclonal
antibody (mAb) and chemically bond DNA that
required in the conventional IPCR, a recombinant
phage particle is applied as a ready reagent for IPCR
experiment. The surface displayed single chain vari-
able fragment (scFv) and phage DNA themselves
can directly serve as detection antibody and PCR
template, respectively. The aim of the design is to
overcome shortcoming of low detection sensitivity
of scFv so as to largely facilitate the real application
of scFv in immunoassay. The idea has been demon-
strated by applying hantaan virus nucleocapsid pro-
tein (NP) and prion protein (PrP) as detection targets
in three experimental protocols (indirect, sandwich
and real-time PD-IPCR assays). The detection sensit-
ivity was increased 1000- to 10 000-folds compared
with conventional enzyme-linked immunosorbent
assays (ELISAs). This proof-of-concept study may
serve as a new model to develop an easy to operate,
low cost and ultrasensitive immunoassay method
for broad applications.
INTRODUCTION
Immuno-PCR (IPCR), ﬁrst described by Sano et al. (1), is a
highly promising technique for the ultrasensitive analysis of
antigens. General IPCR approach involves initial capture of a
target analyte with a capture antibody coated on a surface and
subsequent detection with a detection antibody attached with
a DNA marker that can be ampliﬁed by PCR with appropriate
primers. IPCR combines the versatility of enzyme-linked
immunosorbent assays (ELISAs) with the ampliﬁcation power
and sensitivity of PCR. Asaconsequence,IPCRnotonlyleads
to an about 1000- to 10 000-fold gain in sensitivity, as com-
pared to conventional ELISA, but it also reveals a very broad
linear dynamic range of up to six orders of magnitude (2). Due
to the high sensitivity, IPCR has been widely used in detection
of antigens in immunological study and clinical diagnosis
(3–5). Successful application of IPCR relies upon the availab-
ility of monoclonal antibody (mAb) (6). Although production
technologyofmAbsismature,itremainstobealabor-intensive
andhigh-costprocess(7,8).Further,preparationofmAb–DNA
conjugate involves complex covalent coupling chemistry (9),
or stepwise addition of biotinylated antibody, streptavidin
and biotinylated DNA (10).
With the development of antibody technology, engineered
antibody fragments have gained increased interest during last
decade (11). Single chain variable fragment (scFv) (12) is one
of the most popular formats of engineered antibody. A scFv is
the variable domains of a heavy and a light chain (VH and VL)
of its parent antibody, joined with a ﬂexible polypeptide
linker (13). In comparison with mAbs, scFvs have a number
of attractive characteristics. First, they are easy to produce in
large quantity with low cost. Second, their small sizes permit
them to penetrate tissues and solid tumors more rapidly,
showing improved targeting performance (14). Third, a
scFv can be easily fused with another labeling protein, such
as enzyme (15) or ﬂuorescent protein (16), to form a ready
reagent for immunoassay. However, scFv molecules normally
have an apparent afﬁnity that is typically 10- to 1000-fold
lower than their parent mAbs (17), which greatly limits the
real application of scFvs in immunoassays.
To avoid these problems, here we introduce a new immun-
oassay protocol with the aid of phage displayed scFv. Phage
display technology was ﬁrst introduced in 1985 by George
Smith (18) and has been widely used to build peptide and
antibody libraries, from which the desired scFvs or peptides
with speciﬁcity to almost any target are to be screened by
biopanning (19,20). We aim to develop a more reliable,
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method by subtly combining main features of scFv, phage
display and IPCR. The new design is termed PD-IPCR, denot-
ing for phage display mediated IPCR. As proof-of-concept,
nucleocapsid protein (NP) of Hantaan virus and prion protein
(PrP), which have high pathogenicity and cause serious or
fatal human diseases (21–24), were employed as both detec-
tion targets and demonstrative examples for PD-IPCR. The
results are presented herein.
MATERIALS AND METHODS
Materials
The single chain antibody L13, mAb L13 and puriﬁed NP
were from Institute for Viral Disease Control and Prevention,
Chinese Center for Disease Control and Prevention. Single
chain antibody 163 and PrP expression plasmid were construc-
ted by Dr Ji-Bin Zhang (reported elsewhere), and mAb KG9
was donated by TSE Resource Centre (UK).
Preparation of phages
The recombinant TG1 containing pCANTAB5E-scFv was
inoculated into 2· YT culture broth, which contained 2%
glucose and 100 mg/ml ampicillin, and then incubated at
37 C with shaking (250 r.p.m.) until OD600 of the medium
reached 0.5. After being infected with helper phage M13K07
(10
9 p.f.u./ml, Amersham Pharmacia Biotech), the culture was
gently shaken for an additional 1 h at 37 C. The cells were
harvested by centrifugation and transferred to 2· YT medium
containing 100 mg/ml ampicillin and 50 mg/ml kanamycin.
Phages were produced by growing the culture overnight
with shaking at 30 C and then titred by determining the colony
forming unit (CFU).
ELISA
In indirect ELISA, the polystyrene microtitre plate (Maxisorp,
96-wells, Nunc) was coated with 100 ml of 10-fold serial
dilutions of puriﬁed NP in 0.05 M carbonate buffer
(pH 9.6) overnight at 4 C. The negative control well was
coated with carbonate buffer without NP. After blocking
the wells with TBS (Tris Buffered Saline) containing 5%
(w/v) skimmed milk (TBSM), phage in TBSM was applied
to the wells and incubated for 2 h at 37 C. After washing with
TBS, bound phage was detected using horseradish peroxidase
(HRP)-labeled anti-M13 antibody (Amersham Pharmacia
Biotech). Color development was produced by using tetra-
methylbenzidine (TMB). The reaction was stopped with
2MH 2SO4 and absorbance was determined at 450 nm by a
microplate reader (Bio-Tec Instruments, Inc., Winooski, VT).
Sandwich ELISA was carried out with 100 ml of mAb in
0.05 M carbonate buffer (pH 9.6) coated on microtitre
plate, following by addition of 10-fold serial dilutions of
target protein. Phage incubation, washing condition and
signal detection was similar to that of indirect ELISA.
PD-IPCR
The indirect PD-IPCR assays were carried out with the same
steps as described for the ELISA except that the plate was
subjected to PCR, instead of enzyme reaction. After phage
incubation, the plate was washed with TBSET (TBS buffer
containing 5 mM EDTA and 0.1% Tween-20) and distilled
H2O to remove unbound phages. After washing, 50 mlo f
distilled H2O was added into the microtitre wells, and the
plate was then treated with water bath (95 C for 10 min) to
lyse the bound phages. The PCR mixture contained 5 mlo f
phage lysate as template, 1· PCR buffer (Takara), 0.4 mM
each primer (Supplementary Table 1), 0.25 mM dNTP each,
0.01% BSA, 2.5 U rTaq DNA polymerase (Takara) and dis-
tilled H2O in a total volume of 50 ml. The ampliﬁcation
reaction conditions included denaturation at 94 C for
5 min, followed by 30 cycles of 94 C for 45 s, 60 C for
45 s and 72 C for 30 s. The ﬁnal extension was done at
72 C for 5 min. PCR ampliﬁcation was performed in a T1
Thermocycler (Biometra). The 220 bp PCR products were
electrophoresed on a 1.5% agarose gel containing 0.5 mg/ml
ethidium bromide. Band density was determined by densito-
metry using a computer assisted image analyzer (Alpha
Imager 2200, Alpha Innotech Corporation). Immunological
process and PCR condition of sandwich PD-IPCR were
similar to that of sandwich ELISA and indirect PD-IPCR,
respectively.
Real-time PD-IPCR
All the real-time PCRs were carried out with TaqMan probe
using the Opticon PCR machine of MJ Research. The PCR
premix consisted of 5 ml of phage lysate as template, 1· PCR
buffer (Takara), 4.5 mM MgCl2, 0.2 mM each primer
(Supplementary Table 1), 0.8 mM TaqMan probe, 0.25 mM
dNTP each, 0.01% BSA, 2.5 U rTaq DNA polymerase
(Takara) and distilled H2O in a ﬁnal volume of 50 ml. The
step program for PCR was as follows: 94 C for 5 min, fol-
lowed by 50 cycles of 95 C for 45 s, 55 C for 70 s. In addition,
negative control containing no template DNA was included
in each batch of PCR tests. The threshold level was deter-
mined to be above the background signals and the threshold
cycles (Cts) values were set as the cycle at which the
measured ﬂuorescence intersected the cycle threshold line.
Subsequent analysis was accomplished with Excel software
(Microsoft).
RESULTS
Principle of PD-IPCR
The principle of PD-IPCR is depicted in Figure 1. Capture
antibody is ﬁrst coated on solid surface to provide a reaction
platform. Target antigen in sample is then captured by the
immobilized capture antibody. Recombinant phage particle
can thus be anchored through the interaction between the
displayed scFv and the bound target antigen. The phage
DNA is released by heat lysing and serves as template for
PCR. As a consequence, the existence of the target antigen
is determined by detection of the PCR products.
ScFv L13 (25) displayed on M13 phage is speciﬁc to NP of
Hantaan virus (Supplementary Figure 1). The L13 recombin-
ant phages were produced by growing the Escherichia coli
TG1 harboring the recombinant vector pCANTAB5E-L13
and rescued by M13K07 helper phage. After incubation over-
night, the L13 recombinant phage particles were obtained
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experiment for detection of Hantaan virus NP.
Indirect PD-IPCR for purified NP
The sensitivity of PD-IPCR for the detection of NP ( 60 kDa)
was determined in indirect format. The microtitre plate was
coated with 10-fold serial dilutions of puriﬁed NP, followed
by addition of recombinant phages L13. The bound phages
were lysed by heating and then subjected to PCR with primers
speciﬁc to partial VH gene of L13 scFv (Supplementary
Table 1). The presence of 220 bp ampliﬁcation products
were detected by agarose electrophoresis (Figure 2a). The
ampliﬁcation band of PD-IPCR was quantiﬁed by a computer
assisted image analyzer. Band intensity of the PCR products
increased proportionally with the amount of antigen in the
sample. The results of electrophoresis and intensity analysis
indicated that the lowest level of NP detected by indirect
PD-IPCR was 10 pg/ml ( 0.16 fmol/ml) (Figure 2). No
DNA band was observed in negative control samples without
NP coating (Figure 2a, lane 8). This sensitivity is about four
orders of magnitude higher than that of ELISA dose-response
assay using the same phages (Figure 2b).
To further compare the detection limit of conventional
ELISA and PD-IPCR, the CFU assay was performed. The
amount of NP in plates receiving phages was determined
by infecting E.coli TG1 with the phages bound to each well
and counting the CFU by standard CFU assays (26). The
results suggested that about 10
5 CFU in ELISAs was needed
for color development, while, in PCR tests, a detection limit
of 10
2 CFU was observed (Supplementary Figure 2). The
high ampliﬁcation power gives PD-IPCR the potential for
higher detection sensitivity than ELISA.
Real-time indirect PD-IPCR for purified NP
Real-time PCR detection (27,28) was employed in indirect
PD-IPCR experiments using TaqMan probe (Supplementary
Table 1). Figure 3a shows mean threshold cycles (Cts) of
22.23, 22.65, 23.47, 25.26, 26.61, 28.46, for 10-fold serial
dilutions of the puriﬁed NP from 1 mg/ml to 10 pg/ml,
while 31.68 for the control without NP coating. This result
indicated that the Ct values increase with the decrease of
Figure 2. Detection sensitivity of indirect PD-IPCR and ELISA for NP.
(a) Indirect PD-IPCR experiment. The polystyrene microtitre plate was coated
with 100 ml of 10-fold serial dilutions of NP. Bound phages were used for PCR
andamplificationproductswererunona1.5%agarosegel.Lane1to7represent
amplification products from 10
6 to 1 pg/ml. Lane 8 was negative control
without NP coating. Lane M is DNA marker (DL2000) with 2000, 1000,
750, 500, 250 and 100 bp. (b) Sensitivity comparison between PD-IPCR
and ELISA. The amplification band of PD-IPCRwas quantifiedby a computer
assisted image analyzer. The color development in ELISA was achieved
with HRP-labeled anti-M13 monoclonal conjugate secondary antibody and
TMB substrate. Average values of three independent experiments are given.
Figure 1. Schematic diagram of phage display mediated IPCR.
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(NP)/ml ( 0.16 fmol/ml), which corresponded to an about
10000-fold increase in sensitivity as compared to the
ELISA under analogous conditions. A linear regression of
the signals obtained for the spiked puriﬁed NP against the
logarithmic concentrations from 200 ng/ml to 0.8 ng/ml is
well (R
2 ¼ 0.99) (Figure 3b).Use of this regression curve
for the quantiﬁcation of the NP with 50 and 1 ng/ml yields
a recovery of 72.6 and 126.0%, respectively. These results
evidenced that real-time PD-IPCR is a sensitive detection
method with high reproducibility.
Sandwich PD-IPCR and real-time sandwich PD-IPCR
for purified NP
Due to the multimerization in nature (29,30), Hantaan virus
NP offers multiple unique epitopes for certain antibody.
Thus, it is possible to perform sandwich PD-IPCR assay of
NP using phage displayed L13 scFv as detection antibody
and its parent mAb L13 as the capture antibody. The result
of sandwich PD-IPCR is shown in Figure 4, a detection
limit of 10 pg (NP)/ml was achieved, corresponding to an
about 10000-fold increase in sensitivity as compared to the
sandwich ELISA. When real-time PCR was used as the read-
out method of sandwich PD-IPCR, similar detection sensitiv-
ity was achieved (Figure 3c), and the linear regression was
good (R
2 ¼ 0.96) for the signals of spiked samples against the
logarithmic concentrations from 2000 to 2 ng/ml (Figure 3d).
To study accuracy and reproducibility of PD-IPCR, the
intra-assay precision was determined with three duplicates
for real-time sandwich PD-IPCR, and inter-assay variation
was determined from the results of three independent experi-
ments in three days. Both intra-assay and inter-assay were
carried out using two different concentrations of NP (4 ng/ml
and 400 ng/ml). As shown in Table 1, variation coefﬁcients
(CV) were 0.12–2.46% and 4.77–10.90% for the intra-assay
and inter-assay, respectively. CV for intra-assay was calcu-
lated with the Ct variation from the Ct mean value, while CV
for inter-assay was based on the concentration variation of the
spiked puriﬁed NP from the concentration mean value.
Sandwich PD-IPCR for PrP
As the second demonstrative example, PrP was detected by
the sandwich PD-IPCR. The experiment protocol was
similar to that of NP detection process, but using mAb
Figure 3. Real-timequantitativePD-IPCRassayofNP.(a)QuantitativecurveofindirectPD-IPCRforpurifiedNP.CurvesA–Frepresentserial10-folddilutionsof
NPfrom10
6pg/mlto10pg/ml.GstandsforthenegativecontrolIthathadnoNPantigencoating.NofluorescentsignalwasobservedfornegativecontrolIIthathad
no any template. Note the high similarity of the duplicate determinations, the regular intervals between the signals of the 10-fold dilutions and the difference
betweenthecontrolIandthecontrolII.(b)CalibrationplotoflogpurifiedNPconcentrationversusthresholdcycles(Cts)inindirectPD-IPCR.NPcoatingwas100ml
of 4-fold serial dilutions from 200 to 0.8 ng/ml. The results from three individual experiments were averaged, and the error bars give the SD. (c) Quantitative curve
ofsandwichPD-IPCRforpurifiedNP.Theplatewascoatedwith100mlofL13mAb.CurvesA–Frepresentserial10-folddilutionsofNPfrom10
6pg/mlto10pg/ml,
eachhadtwoduplicates.GstandsforthenegativecontrolIthathadnoNPcoating.NofluorescentsignalwasobservedfornegativecontrolIIthathadnoanytemplate.
(d) Calibration plot of log purified NP concentration versus Ct in sandwich PD-IPCR. The plate was coated with 100 ml of L13 mAb, followed by the addition of
4-fold serial dilutions of NP from 2000 to 2 ng/ml. Again, the results from three individual experiments were averaged, and the error bars give the SD.
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the detection antibody. The results suggested that 1000
increased sensitivity was achieved compared with ELISA
(Figure 5).
DISCUSSION
It is known that low afﬁnity and avidity of scFv to speciﬁc
antigen have a negative impact on its detection sensitivity. To
increase the afﬁnity and avidity of scFv, afﬁnity maturation
(31)andmultimerization(32)ofantibodyfragmentshavebeen
applied. Nevertheless, the improvement by these approaches
has been limited. Whereas, the ampliﬁcation power of the
proposed method based on phage displayed scFv and PCR
protocol greatly improved the detection sensitivity. For
example, 10 pg/ml (~0.16 fmol/ml) of hantaan virus NP
could be detectable with acceptable reproducibility. In addi-
tion, expression efﬁciency of scFvs is strongly inﬂuenced by
their amino acid sequences (33), so far there is no universal
high expression system for all kinds of scFvs yet. In fact, in
many cases, it is difﬁcult to obtain adequate high pure scFvs,
which has become another obstacle for real application of
scFv in vitro immunological analysis. In PD-IPCR, the
scFvs are displayed on the surface of the phage particles
that themselves as a whole can serve as the detection antibody
carrying DNA, so that additional production and puriﬁcation
of scFv are not necessary. Indeed, phage display is a mature
technique that can display a broad range of scFvs without
captiousness. Further more, preparation of phage particles
through E.coli cultivation is a rather simple and reliable
process.
The PD-IPCR method offers two merits over the conven-
tional IPCR. First, the recombinant phage particle is almost as
a ‘ready to use’ reagent because the phage particles carry
both scFv and DNA to be ampliﬁed and they can be obtained
by simply centrifugating the overnight E.coli culture broth.
These features obviate the need for complicated conjugation
chemistry for attaching DNA to the antibody in conventional
IPCR, while avoid the production of mAb that needs both
hybridoma cell culture and afﬁnity chromatography, which
take several days and are expensive. Second, the approach
should be general for almost any target with the fact that
countless antibodies and peptides have been selected from
phage display libraries.
However, although markedly increase in sensitivity as
compared to ELISA the sensitivity of PD-IPCR is not as
high as that of mAb-based IPCR. This is mainly because of
the application of the scFv, whose afﬁnity to antigen is norm-
ally lower than its parent mAb. Screening and using the
higher afﬁnity scFv or peptide are always expected to improve
the detection sensitivity further. Another reason is the non-
speciﬁc adsorption of recombinant phages to the microplate
surface. As seen in Figure 3a, weak ﬂuorescence signal was
observed with the negative control I that had no NP coating
(curve G). Working conditions were investigated, TBSET and
Table 1. Intra-assay and inter-assay precision for real-time sandwich PD-IPCR of hantaan virus NP
Concentration spiked (NP
*) Run1 Run2 Run3
Recovery
* CV (%)
a Recovery
* CV (%)
a Recovery
* CV (%)
a CV (%)
b
4 3.85 1.16 3.65 1.13 3.50 2.46 4.77
400 358.01 0.55 405.82 0.12 445.76 1.14 10.90
aintra-assay coefficient of variation (CV).
binter-assay coefficient of variation (CV).
*ng/ml.
Figure 5. Detection sensitivity of sandwich PD-IPCR and sandwich
ELISA for PrP. The amplification band of PD-IPCR was quantified by a
computer assisted image analyzer. The color development in ELISA was
achieved with HRP-labeled anti-M13 monoclonal conjugate secondary
antibodyandTMBsubstrate.Averagevaluesofthreeindependentexperiments
are given.
Figure 4. Detection sensitivity of sandwich PD-IPCR and sandwich ELISA
for NP. The amplification band of sandwich PD-IPCR was quantified by a
computer assisted image analyzer. The color development in sandwich
ELISA was achieved with HRP-labeled anti-M13 monoclonal conjugate sec-
ondary antibody and TMB substrate. Average values of three independent
experiments are given.
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reagents. Under these conditions, the background noise was
largely reduced (Supplementary Figure 3).
CONCLUSIONS
In summary, the experiment data show that the PD-IPCR
principle shares main advantages of scFv, IPCR and phage
display, greatly facilitating the real application of scFv in
immunoassay. Another point, the protocol completely avoids
complex processes of antibody production and antibody-DNA
conjugation in conventional IPCR. Sensitivity of PD-IPCR
could be further improved through optimization experiments.
We believe the proposed method has broad sense in immun-
oassay of wide variety of antigens.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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